Training | 2019.08.14
Human amniotic fluid stem cells show promise in treating severest type of spinal bifida
A study released today in STEM CELLS Translational Medicine provides compelling evidence of how an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele (MMC).
(PRWeb August 14, 2019)
Read the full story at https://www.prweb.com/releases/human_amniotic_fluid_stem_cells_show_promise_in_treating_severest_type_of_spinal_bifida/prweb16503371.htm
For more information, please visit
https://www.prweb.com/releases/human_amn[...]pinal_bifida/prweb16503371.htm
